Healthcare provider profile · identity verified

James P. Langon, M.D.

Family Practice · FRACKVILLE, PA · NPI 1285694281

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	812	271
Amlodipine Besylate	Amlodipine Besylate	462	155
Lisinopril	Lisinopril	433	146
Losartan Potassium	Losartan Potassium	427	142
Levothyroxine Sodium	Levothyroxine Sodium	394	124
Metoprolol Succinate	Metoprolol Succinate	304	92
Omeprazole	Omeprazole	269	92
Rosuvastatin Calcium	Rosuvastatin Calcium	249	90
Metformin Hcl	Metformin Hcl	234	81
Pantoprazole Sodium	Pantoprazole Sodium	223	67
Simvastatin	Simvastatin	202	69
Gabapentin	Gabapentin	183	47
Furosemide	Furosemide	181	68
Metoprolol Tartrate	Metoprolol Tartrate	160	52
Jardiance	Empagliflozin	136	36
Hydrochlorothiazide	Hydrochlorothiazide	131	44
Albuterol Sulfate Hfa	Albuterol Sulfate	130	52
Sertraline Hcl	Sertraline Hcl	121	36
Ozempic	Semaglutide	119	25
Eliquis	Apixaban	115	33
Warfarin Sodium	Warfarin Sodium	115	38
Clopidogrel	Clopidogrel Bisulfate	114	39
Metformin Hcl Er	Metformin Hcl	113	40
Atenolol	Atenolol	98	35
Allopurinol	Allopurinol	97	32
Famotidine	Famotidine	97	30
Escitalopram Oxalate	Escitalopram Oxalate	92	33
Alprazolam	Alprazolam	91	35
Citalopram Hbr	Citalopram Hydrobromide	88	27
Alendronate Sodium	Alendronate Sodium	86	27
Montelukast Sodium	Montelukast Sodium	82	27
Duloxetine Hcl	Duloxetine Hcl	79	29
Ezetimibe	Ezetimibe	78	26
Ibuprofen	Ibuprofen	72	21
Fluticasone Propionate	Fluticasone Propionate	70	31
Lorazepam	Lorazepam	70	21
Tamsulosin Hcl	Tamsulosin Hcl	69	27
Baclofen	Baclofen	68	21
Carvedilol	Carvedilol	68	22
Chlorthalidone	Chlorthalidone	64	18
Glipizide Er	Glipizide	62	22
Potassium Chloride	Potassium Chloride	61	25
Tramadol Hcl	Tramadol Hcl	61	18
Glimepiride	Glimepiride	60	21
Pravastatin Sodium	Pravastatin Sodium	60	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	21
Trazodone Hcl	Trazodone Hcl	52	18
Synthroid	Levothyroxine Sodium	49	16
Fluoxetine Hcl	Fluoxetine Hcl	48	16
Pregabalin	Pregabalin	48	12
Ropinirole Hcl	Ropinirole Hcl	48	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	21
Buspirone Hcl	Buspirone Hcl	46	17
Oxycodone Hcl	Oxycodone Hcl	44	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Benazepril Hcl	Benazepril Hcl	37	13
Hydroxyzine Hcl	Hydroxyzine Hcl	37	19
Irbesartan	Irbesartan	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	12
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Finasteride	Finasteride	35	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	16
Valacyclovir	Valacyclovir Hcl	35	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	15
Valsartan	Valsartan	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	12
Lansoprazole	Lansoprazole	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Topiramate	Topiramate	31	suppressed
Meloxicam	Meloxicam	30	12
Amoxicillin	Amoxicillin	28	22
Esomeprazole Magnesium	Esomeprazole Magnesium	28	11
Mounjaro	Tirzepatide	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	12
Azithromycin	Azithromycin	26	22
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Unifine Pentips	Pen Needle, Diabetic	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Torsemide	Torsemide	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	21
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	11
Midodrine Hcl	Midodrine Hcl	22	suppressed
Naproxen	Naproxen	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Prednisone	Prednisone	18	12
Nitroglycerin	Nitroglycerin	17	13
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Glipizide	Glipizide	15	suppressed
Ramipril	Ramipril	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Levoxyl	Levothyroxine Sodium	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Clonidine Hcl	Clonidine Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error